These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9780546)

  • 1. Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Leukoreduction: the techniques used, their effectiveness, and costs.
    Int J Technol Assess Health Care; 1998; 14(3):586-8. PubMed ID: 9780546
    [No Abstract]   [Full Text] [Related]  

  • 2. Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA).
    Int J Technol Assess Health Care; 1995; 11(3):628-9. PubMed ID: 7591560
    [No Abstract]   [Full Text] [Related]  

  • 3. Report from the Canadian Coordinating Office of Health Technology Assessment (CCOHTA). Satellite symposium to the eighth annual meeting of the International Society of Technology Assessment in Health Care (ISTAHC).
    Int J Technol Assess Health Care; 1993; 9(2):311-2. PubMed ID: 8458709
    [No Abstract]   [Full Text] [Related]  

  • 4. Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Reuse of single-use cardiac catheters.
    Int J Technol Assess Health Care; 1991; 7(4):637-8. PubMed ID: 1778708
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the Canadian Coordinating Office for Health Technology Assessment.
    Battista RN; Feeny DH; Hodge MJ
    Int J Technol Assess Health Care; 1995; 11(1):102-16. PubMed ID: 7706007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Experimental drug policies in Canada.
    Int J Technol Assess Health Care; 1992; 8(2):367-8. PubMed ID: 1628919
    [No Abstract]   [Full Text] [Related]  

  • 7. TENS: CCOHTA (Canadian Coordinating Office for Health Technology Assessment) responds.
    Menon D
    Leadersh Health Serv; 1996; 5(1):12-3. PubMed ID: 10154220
    [No Abstract]   [Full Text] [Related]  

  • 8. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Magnetic field strength issues in magnetic resonance imaging (MRI).
    Int J Technol Assess Health Care; 1993; 9(4):590-3. PubMed ID: 8288436
    [No Abstract]   [Full Text] [Related]  

  • 9. Reports from the Canadian coordinating office for Health Technology Assessment (CCOHTA).
    Int J Technol Assess Health Care; 1999; 15(2):436-7. PubMed ID: 10507200
    [No Abstract]   [Full Text] [Related]  

  • 10. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Selective serotonin reuptake inhibitors for major depression.
    Int J Technol Assess Health Care; 1998; 14(2):394-6. PubMed ID: 9611913
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges, choices, and Canada.
    Sanders JM
    Int J Technol Assess Health Care; 2002; 18(2):199-202. PubMed ID: 12053420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Funding the new biologics--what can we learn from infliximab? The CCOHTA report: a gastroenterologist's viewpoint.
    Hilsden R
    Can J Gastroenterol; 2002 Dec; 16(12):865-8. PubMed ID: 12522477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Funding the new biologics--a health economic critique of the CCOHTA report: infliximab for the treatment of Crohn's disease.
    Mitton CR;
    Can J Gastroenterol; 2002 Dec; 16(12):873-6. PubMed ID: 12522479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada.
    Int J Technol Assess Health Care; 1995; 11(4):796-7. PubMed ID: 8567213
    [No Abstract]   [Full Text] [Related]  

  • 15. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). HMG-CoA reductase inhibitors: a review of published clinical trials and pharmacoeconomic evaluations.
    Int J Technol Assess Health Care; 1998; 14(2):396-8. PubMed ID: 9678976
    [No Abstract]   [Full Text] [Related]  

  • 16. Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Photodynamic therapy.
    Int J Technol Assess Health Care; 1994; 10(4):711-3. PubMed ID: 7843892
    [No Abstract]   [Full Text] [Related]  

  • 17. Internet information sources for the identification of emerging health technologies. A starting point.
    Trindade E; Topfer LA; De Giusti M
    Int J Technol Assess Health Care; 1998; 14(4):644-51. PubMed ID: 9885454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions.
    Hébert PC; Fergusson D; Blajchman MA; Wells GA; Kmetic A; Coyle D; Heddle N; Germain M; Goldman M; Toye B; Schweitzer I; vanWalraven C; Devine D; Sher GD;
    JAMA; 2003 Apr; 289(15):1941-9. PubMed ID: 12697796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Coordinating Office for Health Technology Assessment.
    Menon D
    CMAJ; 1992 Jan; 146(2):113. PubMed ID: 1735034
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical outcomes following institution of universal leukoreduction of blood transfusions for premature infants.
    Fergusson D; Hébert PC; Lee SK; Walker CR; Barrington KJ; Joseph L; Blajchman MA; Shapiro S
    JAMA; 2003 Apr; 289(15):1950-6. PubMed ID: 12697797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.